|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Thomas_McCourt
|
|
gptkbp:focus
|
gastrointestinal diseases
|
|
gptkbp:foundedYear
|
1998
|
|
gptkbp:founder
|
gptkb:Gregory_P._Barrett
gptkb:Mark_Currie
gptkb:Peter_Hecht
gptkb:Thomas_A._Giordano
|
|
gptkbp:headquartersLocation
|
gptkb:Boston,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ironwood Pharmaceuticals
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:notableCollaboration
|
gptkb:Allergan
gptkb:AstraZeneca
gptkb:AbbVie
|
|
gptkbp:numberOfEmployees
|
~200
|
|
gptkbp:product
|
gptkb:IW-3300
gptkb:linaclotide
|
|
gptkbp:productApprovedBy
|
gptkb:FDA
|
|
gptkbp:productApprovedIn
|
gptkb:Europe
gptkb:Japan
gptkb:United_States
|
|
gptkbp:productType
|
prescription drugs
|
|
gptkbp:publiclyTraded
|
true
|
|
gptkbp:researchArea
|
gastroenterology
|
|
gptkbp:specialty
|
irritable bowel syndrome
chronic idiopathic constipation
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:IRWD
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ:_IRWD
|
|
gptkbp:website
|
https://www.ironwoodpharma.com/
|
|
gptkbp:bfsParent
|
gptkb:Polaris_Partners
|
|
gptkbp:bfsLayer
|
4
|